AI Revolutionizes Healthcare: FDA Clears 'Brain Mets', UK Expands ER Tool, and More

Hi there,

Welcome to the latest edition of Life AI Weekly, where we delve into the transformative role of artificial intelligence in healthcare and life sciences. This week, we explore a range of innovative collaborations and technological advancements. Medicus Pharma and Reliant AI have joined forces to enhance clinical trial analytics, focusing on optimizing site selection and patient stratification. Meanwhile, MEDIROM Healthcare Technologies is working with Tools for Humanity and World Foundation to implement 'Proof of Human' technology in Japan, aiming to address the challenge of distinguishing humans from AI online.

In other news, China's biotech sector is making significant strides in clinical trials, with HELP Therapeutics leading advancements in cell therapy for heart failure. Senhwa Biosciences has highlighted its AI-driven oncology advances, focusing on its lead compound, Silmitasertib. Additionally, Pinnacle Blooms Network has secured a $70 million investment to expand its AI-powered Child Development Operating System, GPT-OS, enhancing therapy centers and home-based services. Stay tuned as we continue to bring you the latest developments in AI and healthcare.

Medicus Pharma Partners with Reliant AI for Clinical Trial Analytics

Medicus Pharma has partnered with Reliant AI to develop an AI-powered platform to improve clinical trial execution. The collaboration will focus on enhancing decision-making through AI technology. Read more

MEDIROM Partners to Deploy 'Proof of Human' Tech in Japan

MEDIROM Healthcare Technologies has teamed up with Tools for Humanity and World Foundation to roll out 'Proof of Human' verification technology across Japan, aiming to differentiate humans from AI online. Read more

China's Biotech Sector Uses AI in Clinical Trials

China's biotechnology sector is advancing in global clinical trials, surpassing the U.S. with increased R&D investment and talent. HELP Therapeutics showcased cell therapy advancements at a major forum, highlighting China's multinational clinical development capabilities. Read more

Senhwa Biosciences Highlights AI-Driven Oncology Advances

Senhwa Biosciences presented its AI-enabled drug development platform and strategic collaborations at its 2025 annual investor conference, focusing on its lead compound, Silmitasertib, and a new collaboration with BeOne Medicines. Read more

Pinnacle Blooms Network Receives $70M for AI Expansion

Pinnacle Blooms Network has secured a $70 million investment to expand its AI-powered Child Development Operating System, aiming to grow therapy centers and enhance services. Read more

MDGenius AI Launches Platform for Aesthetic Medicine

MDGenius AI has launched a new platform aimed at transforming operations in the aesthetic medicine industry. The platform offers modules for patient communication, sales optimization, preoperative management, and postoperative care, and is designed to meet the needs of healthcare providers in this sector. Read more

BAIC and BHC Launch AI Validation Platform for Healthcare

The Basque Artificial Intelligence Center (BAIC) and Basque Health Cluster (BHC) have launched TRUST-OSAI, a platform designed to validate AI solutions in healthcare, ensuring compliance with European regulations. Read more

UK Expands AI Tool for Predicting ER Demand

The UK Government has expanded its AI tool to predict demand in A&E departments, now used by 170 users across 50 NHS organizations. This aims to improve patient care by enhancing planning and reducing waiting times. Read more

Akara Launches AI Robotics Startup for Hospital Efficiency

Akara has introduced an AI-driven robotics startup designed to minimize delays in hospital operating rooms, utilizing thermal sensors and AI for real-time monitoring. Read more

MDGeniusAI Launches AI Platform for Surgical Safety

Miami-based healthcare technology company MDGeniusAI has introduced an AI platform designed to detect surgical complications early, enhancing patient safety in aesthetic medicine. Read more

UNDP Uses AI X-Ray Tech for TB Diagnosis in Turkmenistan

The UNDP has launched AI-driven portable X-ray units to enhance tuberculosis screening in Turkmenistan, supported by the Global Fund. This effort focuses on improving healthcare access and efficiency in remote regions using CAD4TB software for quick X-ray analysis. Read more

FDA Clears AI Software 'Brain Mets' for Brain Metastases

The FDA has approved the AI software 'Brain Mets' by Neosoma for enhancing brain metastases assessment using MRI scans. Read more

Corti's IPO Plans Delayed Beyond 2026

Danish healthcare AI startup Corti has announced plans to go public, but CEO Andreas Cleve confirmed that this will not occur in 2026. The company is known for its AI infrastructure in healthcare, managing numerous patient interactions daily. Read more

AI Model Predicts Language Outcomes in Deaf Children

Researchers at Ann and Robert H. Lurie Children's Hospital of Chicago have developed an AI model that predicts spoken language outcomes for deaf children after cochlear implants with 92% accuracy. The model analyzes pre-implantation brain MRI scans to identify children who may need additional therapy. Read more

UltraGreen.ai Gains Approval for AI Health Solutions in Southeast Asia

UltraGreen.ai, a Singapore-based company, has obtained regulatory approvals for its Verdye product in the Philippines and the IC-Flow Imaging System V2 in Malaysia, enhancing surgical capabilities in the region. Read more

Pragmatech Secures €650k for AI Antibiotic Software

Pragmatech, a Spanish HealthTech startup, has raised €650k to enhance the deployment of its AI antibiotic prescribing software, iAST®. The funding aims to improve clinical decision-making and reduce prescribing errors. Read more

Categories

Companies

Resources

AI Revolutionizes Healthcare: FDA Clears 'Brain Mets', UK Expands ER Tool, and More - Life AI Weekly #48

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly